Continuum Advisory’s Kymera Therapeutics KYMR Stock Holding History

Continuum Advisory’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13	Closed	-$502	–	1733
2024 Q1	$502	Buy	+13	New	+$465	﹤0.01%	1608

Other funds holding KYMR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Continuum Advisory's KYMR Position: Q2 2024 in Review

Continuum Advisory sold out of Kymera Therapeutics (KYMR) in Q2 2024, closing a stake of 13 shares — an estimated $502 sold.

Continuum Advisory first reported a position in KYMR in Q1 2024 and held it in 1 quarter. The position peaked at $502 in Q1 2024. 157 funds tracked by Wall St. Rank hold KYMR as of Q2 2024.

Continuum Advisory reported no remaining Kymera Therapeutics position as of Q2 2024 after selling out during the quarter.
Continuum Advisory sold 13 Kymera Therapeutics shares in Q2 2024, an estimated $502.
Continuum Advisory first reported a position in Kymera Therapeutics in Q1 2024 and held it in 1 quarter.
Continuum Advisory's Kymera Therapeutics position peaked at $502 in Q1 2024.
157 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2024.

Based on Continuum Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.